Comparison of the effectiveness of equal doses of short and long-acting erythrocyte stimulating agents for managing anemia in chronic kidney disease adult patients

Abstract

Anemia is the most common side effect in patients with chronic kidney disease (CKD) mainly due to lower levels of erythropoietin (EPO) hormone. The aim of the present study is to compare the efficacy of equivalent doses of erythropoiesis stimulating agents (ESAs): short acting (Eprex®; Epoetin alfa) and long acting (Darbepoetin alfa: DA) in the treatment of anemia of CKD adult patients treated from September 2013 to January 2015. A total of fifty five patients were included; 22 patients were treated with Eprex®® (Epoetin alfa) and 33 patients received DA. Different blood indices were assessed in the initial 8 weeks. The equality of the doses was based on the conversion formula (1 µg of DA = 300 IU Eprex®). Treatment with lower dose of DA (0.64±0.07 µg/kg QW) induced a significant increase in hemoglobin (Hb) from week 4 through week 8, while red blood corpuscles (RBCs) and hematocrit (Hct) were significantly elevated in week 8. A significant increase in Hb and Hct were observed starting from week 2 through week 8 parallel with a significant rise in RBCs count, starting from week 3 through week 8 after treatment with DA (0.8±0.06 µg/kg QW), while a significant increment of Hb and Hct were noticed after treatment with DA (1.215±0.11 µg/kg QW) from week 3 to week 7. Administration of higher dose DA (1.37±0.22 µg/kg QW) led to a significant rise of RBCs in week 3, 6 and 7 while Hb and Hct in week 6 and 7. Treatment with equal doses of Eprex® (170.85±16.4 IU/kg and 238±25 .9 IU/kg) induced only a mild increase in RBCs in week 7 and 6 respectively, while higher dose of Eprex® (413±40.8 IU/kg) elevated RBCs significantly at week 8 and Hct in week 6 and 8. Administration of DA QW is more effective than Eprex® QTIW in terms of target anemia parameters: RBCs, Hb and Hct during the first 8 weeks of administration.

Authors and Affiliations

Abdulmalik Alkatheri| Pharmaceutical Care Department, King Abdulaziz Medical City, National Guard Health Affairs, Riyadh, 11426, KSA, College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, NGHA, Riyadh 11481, Saudi Arabia, Corresponding E-mail: katheria@ngha.med.sa, Abdelkareem Albekairy| Pharmaceutical Care Department, King Abdulaziz Medical City, National Guard Health Affairs, Riyadh, 11426, KSA, College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, NGHA, Riyadh 11481, Saudi Arabia, Yousef Al-Rajhi| Pharmaceutical Care Department, King Abdulaziz Medical City, National Guard Health Affairs, Riyadh, 11426, KSA, Shamylan AlHarbi| Pharmaceutical Care Department, King Abdulaziz Medical City, National Guard Health Affairs, Riyadh, 11426, KSA, College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, NGHA, Riyadh 11481, Saudi Arabia, Khalifah Alkhamees| Pharmaceutical Care Department, King Abdulaziz Medical City, National Guard Health Affairs, Riyadh, 11426, KSA, Fayez F. Hejaili| Division of Nephrology, King Abdulaziz Medical City, National Guard Health Affairs, Riyadh, 11426, KSA, Rami Bustami| College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, NGHA, Riyadh 11481, Saudi Arabia, Wesam Abdel-Razaq| College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, NGHA, Riyadh 11481, Saudi Arabia, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid 22110, Jordan, Amjad M. Qandil| College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, NGHA, Riyadh 11481, Saudi Arabia, Mahmoud Mansour| College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, NGHA, Riyadh 11481, Saudi Arabia

Keywords

Related Articles

Simultaneous Detection of Methicillin- and Mupirocin-Resistant genes in Staphylococcus aureus Isolated with Multiplex PCR from Patients in the City of Darab, Fars Province, Iran

Background and Objectives: Methicillin-resistant Staphylococcus aureus (MRSA) is one of the most important pathogens in hospitals. Hospital staffs can be one of the main sources of this organism in nosocomial infections...

The impact of Behavior Excellence courses on communication skills of NAJA employees

The aim of this study was to evaluate the effects of treatment on, communication skills of NAJA employees. The sample were consisted of 40 NAJA personnel of the city of Abadan (experimental group) and 40 city NAJA perso...

PSYCHOSOCIAL DETERMINANTS OF CONTRACEPTIVE USE AMONG WOMEN OF REPRODUCTIVE AGE IN A RURAL AREA OF MAHARASHTRA

The World Health Organisation reports that an estimated 94 per cent of the population of the world lives in countries with policies that favour family planning. Despite this, five of every six couples of reproductive ag...

Sickle Beta Plus Talassemia Presenting as Acute Pancreatitis – A Case Report

Sickle beta plus thalassemia (Hb S/β+ Th) is a rare inherited disorder among haemoglobinopathies. This disorder is inherited in an autosomal recessive manner. Sickle beta plus thalassemia patient usually have chronic h...

PREVALENCE OF HEALTH CARE ASSOCIATED INFECTIONS IN A TERTIARY CARE HOSPITAL IN DAKSHINA KANNADA, KARNATAKA: A HOSPITAL BASED CROSS SECTIONAL STUDY

Background: Health Care-Associated Infections (HCAI) affect millions of people each year and raise a great risk for patients in health care settings, leading to high rates of morbidity and mortality. Objective: To estim...

Download PDF file
  • EP ID EP12245
  • DOI -
  • Views 284
  • Downloads 16

How To Cite

Abdulmalik Alkatheri, Abdelkareem Albekairy, Yousef Al-Rajhi, Shamylan AlHarbi, Khalifah Alkhamees, Fayez F. Hejaili, Rami Bustami, Wesam Abdel-Razaq, Amjad M. Qandil, Mahmoud Mansour (2016). Comparison of the effectiveness of equal doses of short and long-acting erythrocyte stimulating agents for managing anemia in chronic kidney disease adult patients. International Journal of Medical Research & Health Sciences (IJMRHS), 5(12), 335-342. https://europub.co.uk/articles/-A-12245